Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2005.064451v1, 2006; 10.1373/clinchem.2005.064451
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.064451v1
52/10/1851    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niedrig, M.
Right arrow Articles by Drosten, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niedrig, M.
Right arrow Articles by Drosten, C.

Received on November 28, 2005
Accepted on July 6, 2006

Molecular Diagnostics and Genetics

First International Proficiency Study on West Nile Virus Molecular Detection

Matthias Niedrig 1*, Sonja Linke 1, Herve Zeller 2, Christian Drosten 3

1 Robert Koch Institute, Berlin, Germany
2 Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France
3 Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

* To whom correspondence should be addressed. E-mail: niedrigm{at}rki.de.

Background: West Nile virus (WNV) molecular detection is being conducted by a growing number of laboratories, but the degree of proficiency may vary between them. External quality control is needed.

Methods: We have conducted an international quality assurance study on WNV molecular detection. Participating laboratories tested noninfectious samples inactivated by heat and gamma irradiation. Participants received 7 coded lyophilized samples containing WNV of genetic lineages 1a, 1b, and 2 at 2600 to 18 000 000 RNA copies/mL, 3 samples containing heterologous flaviviruses, and 2 negative samples.

Results: Thirty laboratories participated. The average laboratory achieved 50% detection probability from 7762 copies/mL onward (probit analysis; 95% CI = 1174-24547 copies/mL). Lineages 1a and 1b were detected with equal efficiencies, but the lineage 2 strain (Ug37) was detected at significantly lower rates. Only 27% of participants were able to detect the 6 samples containing ≥1.8 x 104 copies/mL. Three laboratories generated false-positive results in negative samples. Six of 30 laboratories reported correct strain identification in 3 samples containing non-WNV flaviviruses. We observed a significant positive correlation between the capability of detecting non-WNV flaviviruses and detecting WNV lineage 2.

Conclusions: Most participants showed good performance in detecting lineage 1 WNV, the predominant virus in the Northern Hemisphere. The inability of some laboratories to detect even highly concentrated lineage 2 WNV downgraded the overall outcome. The lineage 2 material received through this study will provide laboratories with the necessary template for improving their assays. Such material is otherwise hard to obtain.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Microbiol.Home page
S. Rondini, M. R. Pingle, S. Das, R. Tesh, M. S. Rundell, J. Hom, S. Stramer, K. Turner, S. N. Rossmann, R. Lanciotti, et al.
Development of Multiplex PCR-Ligase Detection Reaction Assay for Detection of West Nile Virus
J. Clin. Microbiol., July 1, 2008; 46(7): 2269 - 2279.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.